SCHEMBL19293154

SCHEMBL19293154

CNCCCCC(=O)NC(C)Cc1ccccc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.56
HDAC3 O15379 1/20 0.53
HDAC4 P56524 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC2 Q92769 1/20 0.53
HDAC10 Q969S8 1/20 0.53
HDAC11 Q96DB2 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
HDAC9 Q9UKV0 1/20 0.53
HDAC5 Q9UQL6 1/20 0.53
SIGMAR1 Q99720 1/20 0.52
LMNA P02545 1/20 0.51
KMT2A Q03164 3/20 0.51
ALDH1A1 P00352 1/20 0.51
TAAR1 Q96RJ0 1/20 0.50
CTSG P08311 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14295054 0.84 SMN1; SMN2 (0.61) NPC1RAB9ASMN1; SMN2KMT2AALDH1A1
SCHEMBL2628428 0.83 HDAC1 (0.60) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL23615410 0.83 MMP2 (0.61) NPC1RAB9ASMN1; SMN2HDAC3HDAC4
SCHEMBL25674461 0.83 MMP2 (0.61) NPC1RAB9ASMN1; SMN2HDAC3HDAC4
SCHEMBL17231646 0.81 NPC1 (0.55) NPC1RAB9ASMN1; SMN2HDAC3HDAC4
SCHEMBL22331980 0.80 RAB9A (0.67) NPC1RAB9ASMN1; SMN2HDAC1HDAC2
SCHEMBL3456224 0.80 RAB9A (0.67) NPC1RAB9ASMN1; SMN2HDAC1HDAC2
SCHEMBL7197881 0.80 NPC1 (0.67) NPC1RAB9ASMN1; SMN2SIGMAR1LMNA
SCHEMBL15107039 0.79 CYP3A4 (0.56) NPC1RAB9ASMN1; SMN2HDAC1HDAC8
SCHEMBL20844610 0.79 NPC1 (0.52) NPC1RAB9ASIGMAR1LMNATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3210998-A1 METASTIN DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2017-08-30 EP disclosed